Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_VTE,ABO,Histo-blood group ABO system transferase,Inverse variance weighted,39,1.23 [1.18-1.29],1.18247758328658e-19,cis
Chapter IX Diseases of the circulatory system,I9_VTE,F10,Coagulation factor X,Inverse variance weighted,9,1.26 [1.17-1.35],9.24310803910533e-10,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.8 [0.72-0.89],4.0540720105912e-05,cis
Chapter IX Diseases of the circulatory system,I9_VTE,OGN,Mimecan,Inverse variance weighted,30,0.91 [0.87-0.95],6.66826450589461e-05,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,0.88 [0.82-0.94],0.000234400752825283,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.94 [0.9-0.98],0.00171931580795187,cis
Chapter IX Diseases of the circulatory system,I9_VTE,VWF,von Willebrand factor,Inverse variance weighted,2,1.29 [1.08-1.55],0.00551309161729166,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SDC1,Syndecan-1,Inverse variance weighted,2,1.24 [1.06-1.44],0.00551423099690082,cis
Chapter IX Diseases of the circulatory system,I9_VTE,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.9 [0.84-0.97],0.00589435572829065,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,0.87 [0.79-0.96],0.00690429459117462,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.93 [0.88-0.98],0.00690543340692873,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.95 [0.91-0.99],0.00727924688733425,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.13 [1.03-1.23],0.00846194278482219,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.85 [0.75-0.97],0.0123057499554773,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.96 [0.92-0.99],0.0197508191008557,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.95 [0.91-0.99],0.0215985077500137,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.95 [0.9-1],0.0312994674200065,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.9 [0.83-0.99],0.0318588345930127,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.93 [0.86-1],0.0361556760582875,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CX3CL1,Fractalkine,Inverse variance weighted,9,0.9 [0.82-0.99],0.0371525548732494,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD83,CD83 antigen,Inverse variance weighted,5,1.12 [1.01-1.24],0.0395033221884831,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.94 [0.88-1],0.0490162365506522,cis
Chapter IX Diseases of the circulatory system,I9_VTE,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.8 [0.63-1],0.0499650605842613,cis
Chapter IX Diseases of the circulatory system,I9_VTE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.22 [1-1.48],0.0508396074653855,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PALM2,Paralemmin-2,Inverse variance weighted,8,1.09 [1-1.19],0.0517263287121601,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.9 [0.81-1],0.0519670986738696,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.7 [0.49-1],0.0525041033227089,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NID1,Nidogen-1,Inverse variance weighted,6,0.91 [0.83-1],0.0561505159649341,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.07 [1-1.16],0.0563662958250297,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CTSL,Cathepsin L1,Wald ratio,1,0.64 [0.41-1.01],0.0566208576238421,cis
Chapter IX Diseases of the circulatory system,I9_VTE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.91 [0.83-1],0.0594955183704216,cis
Chapter IX Diseases of the circulatory system,I9_VTE,AMBP,Protein AMBP,Inverse variance weighted,3,1.14 [0.99-1.31],0.0666523434737024,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,0.97 [0.94-1],0.0688297456317755,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.93 [0.85-1.01],0.0692694479790007,cis
Chapter IX Diseases of the circulatory system,I9_VTE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.08 [0.99-1.17],0.0694615257799912,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SPON1,Spondin-1,Inverse variance weighted,21,0.95 [0.91-1],0.0743859860269563,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.03 [1-1.08],0.0822365422636826,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LGALS1,Galectin-1,Inverse variance weighted,6,0.95 [0.89-1.01],0.0823743256683091,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.95 [0.9-1.01],0.084656401967228,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.92 [0.83-1.01],0.0847083186917936,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.27 [0.97-1.68],0.0862487538694407,cis
Chapter IX Diseases of the circulatory system,I9_VTE,MMP3,Stromelysin-1,Inverse variance weighted,34,1.04 [0.99-1.1],0.0867130866315941,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.12 [0.98-1.29],0.0907374147829601,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.18 [0.97-1.44],0.0929174966581944,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.95 [0.9-1.01],0.0942352437663532,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.9 [0.8-1.02],0.0943751504197707,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.06 [0.99-1.13],0.0944788908718561,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SPP1,Osteopontin,Inverse variance weighted,8,0.89 [0.77-1.02],0.0961816611179135,cis
Chapter IX Diseases of the circulatory system,I9_VTE,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,2,1.45 [0.93-2.28],0.104024281054902,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.08 [0.98-1.2],0.112256128654109,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.06 [0.99-1.13],0.114350846813434,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.04 [0.99-1.09],0.124630849710671,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PGF,Placenta growth factor,Inverse variance weighted,2,1.52 [0.89-2.59],0.126277614509794,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.98 [0.96-1.01],0.126614329977913,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.95 [0.88-1.02],0.130841786234015,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.97 [0.94-1.01],0.133055222763478,cis
Chapter IX Diseases of the circulatory system,I9_VTE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.98 [0.95-1.01],0.133769519488498,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LGALS9,Galectin-9,Inverse variance weighted,26,0.96 [0.92-1.01],0.139056061575795,cis
Chapter IX Diseases of the circulatory system,I9_VTE,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.11 [0.97-1.27],0.139471626794466,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CHGA,Chromogranin-A,Inverse variance weighted,3,1.09 [0.97-1.22],0.144527070645953,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1.03 [0.99-1.06],0.147079901050414,cis
Chapter IX Diseases of the circulatory system,I9_VTE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.87 [0.71-1.05],0.147356324504189,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.97 [0.93-1.01],0.151558232864519,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.04 [0.98-1.1],0.155961996811054,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.9 [0.78-1.04],0.156761482379966,cis
Chapter IX Diseases of the circulatory system,I9_VTE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.85 [0.67-1.07],0.157296280018412,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.91 [0.79-1.04],0.166322249733139,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.08 [0.97-1.2],0.170805699024693,cis
Chapter IX Diseases of the circulatory system,I9_VTE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.02 [0.99-1.06],0.175013837295843,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.97 [0.93-1.01],0.18143461642499,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.07 [0.97-1.19],0.188317322530991,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.94 [0.85-1.03],0.190093905282822,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.02 [0.99-1.05],0.190617479884929,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.95 [0.87-1.03],0.197081207350645,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.96 [0.9-1.02],0.201376689614975,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.92 [0.82-1.04],0.202368109849824,cis
Chapter IX Diseases of the circulatory system,I9_VTE,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.05 [0.97-1.14],0.210785559300451,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,0.89 [0.74-1.07],0.212955803528707,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.03 [0.98-1.09],0.214020838659402,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SPON2,Spondin-2,Inverse variance weighted,4,1.06 [0.97-1.16],0.218670615365838,cis
Chapter IX Diseases of the circulatory system,I9_VTE,KLK4,Kallikrein-4,Inverse variance weighted,17,0.97 [0.92-1.02],0.224698754599065,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.94 [0.86-1.04],0.23083909211532,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.84 [0.63-1.12],0.231163381583124,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.05 [0.97-1.14],0.236871376739268,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.95 [0.88-1.03],0.238464890613979,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.86 [0.67-1.11],0.239329843383803,cis
Chapter IX Diseases of the circulatory system,I9_VTE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [0.98-1.07],0.242525368655516,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.78 [0.51-1.19],0.245436697339593,cis
Chapter IX Diseases of the circulatory system,I9_VTE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.98 [0.95-1.01],0.245596838980029,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.75 [0.46-1.22],0.248035667533934,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.8 [0.55-1.17],0.252560132688522,cis
Chapter IX Diseases of the circulatory system,I9_VTE,OCLN,Occludin,Inverse variance weighted,2,0.91 [0.78-1.07],0.255437632375654,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.03 [0.98-1.09],0.258076940264473,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.03 [0.98-1.08],0.264590931876302,cis
Chapter IX Diseases of the circulatory system,I9_VTE,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.04 [0.97-1.1],0.26526882633206,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IL15,Interleukin-15,Wald ratio,1,2.93 [0.44-19.68],0.268030765910987,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.02 [0.99-1.05],0.269979169813923,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.12 [0.91-1.38],0.2837553567376,cis
Chapter IX Diseases of the circulatory system,I9_VTE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.97 [0.91-1.03],0.28505241619825,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.88 [0.69-1.12],0.285478957434795,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1.03 [0.98-1.09],0.289971928158904,cis
Chapter IX Diseases of the circulatory system,I9_VTE,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.98 [0.93-1.02],0.305509781132988,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD276,CD276 antigen,Inverse variance weighted,20,0.98 [0.94-1.02],0.307618932769322,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.14 [0.88-1.47],0.311407551383122,cis
Chapter IX Diseases of the circulatory system,I9_VTE,BGLAP,Osteocalcin,Inverse variance weighted,2,0.73 [0.4-1.34],0.313074309205159,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.91 [0.75-1.1],0.314718300180366,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PTPRF,Receptor-type tyrosine-protein phosphatase F,Inverse variance weighted,2,1.14 [0.88-1.47],0.316507275658833,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,1.11 [0.9-1.36],0.319053478227851,cis
Chapter IX Diseases of the circulatory system,I9_VTE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.97 [0.91-1.03],0.319348954034503,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD27,CD27 antigen,Inverse variance weighted,9,0.96 [0.88-1.04],0.328588623892526,cis
Chapter IX Diseases of the circulatory system,I9_VTE,BSG,Basigin,Wald ratio,1,1.08 [0.93-1.25],0.330561974737142,cis
Chapter IX Diseases of the circulatory system,I9_VTE,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.03 [0.97-1.09],0.333711559319943,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.94 [0.84-1.06],0.34162549862517,cis
Chapter IX Diseases of the circulatory system,I9_VTE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.03 [0.97-1.1],0.341741660151036,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.02 [0.98-1.07],0.347931941397931,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.02 [0.98-1.06],0.352115916584488,cis
Chapter IX Diseases of the circulatory system,I9_VTE,DRAXIN,Draxin,Inverse variance weighted,13,1.02 [0.98-1.07],0.355652193410513,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NRP2,Neuropilin-2,Inverse variance weighted,11,0.97 [0.9-1.04],0.356589191696124,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SEPTIN8,Septin-8,Inverse variance weighted,2,1.08 [0.92-1.27],0.357700663138028,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.95 [0.85-1.06],0.363570971624945,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.02 [0.98-1.06],0.365325944367848,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.89 [0.69-1.15],0.371549605264544,cis
Chapter IX Diseases of the circulatory system,I9_VTE,AREG,Amphiregulin,Inverse variance weighted,3,1.06 [0.93-1.22],0.37198317437354,cis
Chapter IX Diseases of the circulatory system,I9_VTE,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.02 [0.97-1.07],0.373354359213445,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NECTIN2,Nectin-2,Inverse variance weighted,5,1.05 [0.94-1.17],0.374923611149393,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.03 [0.96-1.11],0.381681567819811,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IL17C,Interleukin-17C,Inverse variance weighted,3,0.91 [0.75-1.12],0.382079619454829,cis
Chapter IX Diseases of the circulatory system,I9_VTE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.97 [0.91-1.04],0.386463322005319,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.06 [0.93-1.2],0.390648961916245,cis
Chapter IX Diseases of the circulatory system,I9_VTE,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.87 [0.62-1.21],0.395489294351146,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.03 [0.96-1.1],0.399145115802161,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.97 [0.89-1.05],0.400269754913735,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.03 [0.96-1.12],0.409907203102912,cis
Chapter IX Diseases of the circulatory system,I9_VTE,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.09 [0.89-1.33],0.413261349969021,cis
Chapter IX Diseases of the circulatory system,I9_VTE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.03 [0.96-1.12],0.413491585985426,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.97 [0.9-1.04],0.416591387458197,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FBLN2,Fibulin-2,Inverse variance weighted,11,0.97 [0.89-1.05],0.416928604299506,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.98-1.05],0.419346453131198,cis
Chapter IX Diseases of the circulatory system,I9_VTE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.04 [0.95-1.13],0.422277969876941,cis
Chapter IX Diseases of the circulatory system,I9_VTE,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.97 [0.91-1.04],0.422659239771815,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.09 [0.88-1.35],0.423705734560239,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.03 [0.96-1.1],0.425771483449889,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.05 [0.93-1.19],0.43101953936904,cis
Chapter IX Diseases of the circulatory system,I9_VTE,VCAN,Versican core protein,Inverse variance weighted,31,0.98 [0.95-1.02],0.433326305084295,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.95 [0.85-1.07],0.435661436657614,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.06 [0.92-1.23],0.436547150249424,cis
Chapter IX Diseases of the circulatory system,I9_VTE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,1.04 [0.94-1.16],0.437620542244345,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.97 [0.88-1.06],0.446014809745617,cis
Chapter IX Diseases of the circulatory system,I9_VTE,VWC2,Brorin,Inverse variance weighted,22,1.02 [0.97-1.08],0.447924388092603,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.02 [0.97-1.06],0.472682200719527,cis
Chapter IX Diseases of the circulatory system,I9_VTE,MB,Myoglobin,Wald ratio,1,0.82 [0.47-1.42],0.473739295160818,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ELN,Elastin,Inverse variance weighted,2,1.25 [0.68-2.29],0.474312712050281,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.06 [0.89-1.27],0.484327621638791,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.89 [0.64-1.23],0.486101679407896,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ANXA10,Annexin A10,Wald ratio,1,0.86 [0.57-1.3],0.486383998741026,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.98 [0.94-1.03],0.489024555116932,cis
Chapter IX Diseases of the circulatory system,I9_VTE,DSC2,Desmocollin-2,Inverse variance weighted,9,1.03 [0.95-1.11],0.490252827084135,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.03 [0.95-1.12],0.497149483460366,cis
Chapter IX Diseases of the circulatory system,I9_VTE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.02 [0.96-1.08],0.498019648391048,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.98 [0.92-1.04],0.499382788013073,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.02 [0.96-1.08],0.501997444005628,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.98 [0.93-1.04],0.510897252790575,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.02 [0.97-1.06],0.514321429100225,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RSPO1,R-spondin-1,Inverse variance weighted,5,1.04 [0.92-1.17],0.522433603567547,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CSTB,Cystatin-B,Inverse variance weighted,28,0.99 [0.95-1.03],0.531101872230534,cis
Chapter IX Diseases of the circulatory system,I9_VTE,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.05 [0.9-1.23],0.538306479682755,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.95 [0.79-1.14],0.55231397907569,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.02 [0.96-1.08],0.557337441064068,cis
Chapter IX Diseases of the circulatory system,I9_VTE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.04 [0.91-1.19],0.559794642851619,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.95 [0.8-1.13],0.563405575258569,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.04 [0.91-1.19],0.567809182951235,cis
Chapter IX Diseases of the circulatory system,I9_VTE,DPT,Dermatopontin,Inverse variance weighted,21,0.96 [0.85-1.09],0.569785537823412,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CCN3,CCN family member 3,Inverse variance weighted,19,1.02 [0.96-1.08],0.57338603648486,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.02 [0.95-1.11],0.574039440988445,cis
Chapter IX Diseases of the circulatory system,I9_VTE,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,0.99 [0.95-1.03],0.577772828858564,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.01 [0.97-1.06],0.579481238652099,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.93 [0.73-1.2],0.589159501757151,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RBP2,Retinol-binding protein 2,Wald ratio,1,0.91 [0.65-1.29],0.595394342639222,cis
Chapter IX Diseases of the circulatory system,I9_VTE,MATN3,Matrilin-3,Inverse variance weighted,28,1.01 [0.97-1.06],0.599879540074182,cis
Chapter IX Diseases of the circulatory system,I9_VTE,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.15 [0.68-1.94],0.60194469229582,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.03 [0.92-1.15],0.60412161715538,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CDH3,Cadherin-3,Inverse variance weighted,2,0.94 [0.74-1.2],0.610659694794587,cis
Chapter IX Diseases of the circulatory system,I9_VTE,AGRN,Agrin,Inverse variance weighted,17,0.98 [0.92-1.05],0.61494303738126,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,0.99 [0.94-1.04],0.618107635728683,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.02 [0.95-1.09],0.619410023733829,cis
Chapter IX Diseases of the circulatory system,I9_VTE,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,0.97 [0.85-1.1],0.620153196593161,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RSPO3,R-spondin-3,Inverse variance weighted,6,0.96 [0.81-1.13],0.626092648585753,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.98 [0.91-1.06],0.626646478105496,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.09 [0.77-1.54],0.627318610621853,cis
Chapter IX Diseases of the circulatory system,I9_VTE,COLEC12,Collectin-12,Inverse variance weighted,11,1.02 [0.94-1.1],0.639996971118031,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.03 [0.91-1.17],0.64356147289563,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.96 [0.81-1.14],0.651347838324675,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.98 [0.91-1.06],0.65426794832388,cis
Chapter IX Diseases of the circulatory system,I9_VTE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.98 [0.89-1.07],0.654475477824436,cis
Chapter IX Diseases of the circulatory system,I9_VTE,THBD,Thrombomodulin,Inverse variance weighted,5,0.98 [0.88-1.08],0.660010461615452,cis
Chapter IX Diseases of the circulatory system,I9_VTE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.02 [0.93-1.12],0.673538553351367,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.01 [0.95-1.08],0.674443558072916,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.99 [0.93-1.05],0.681946895271578,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.01 [0.96-1.06],0.693396850323334,cis
Chapter IX Diseases of the circulatory system,I9_VTE,F7,Coagulation factor VII,Inverse variance weighted,21,1.01 [0.95-1.08],0.699278872938478,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.04 [0.85-1.27],0.699527077166859,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.95 [0.75-1.22],0.704254344826771,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.03 [0.89-1.19],0.705607518995386,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.98 [0.86-1.11],0.709853559367521,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.02 [0.92-1.12],0.724021947535554,cis
Chapter IX Diseases of the circulatory system,I9_VTE,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.02 [0.91-1.14],0.724398819586305,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.99 [0.95-1.03],0.72590667840136,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.08 [0.7-1.64],0.735651237624629,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.02 [0.93-1.12],0.738930692398398,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.02 [0.9-1.17],0.739303885392155,cis
Chapter IX Diseases of the circulatory system,I9_VTE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.99 [0.93-1.05],0.741472498606346,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.97 [0.82-1.16],0.745391071236731,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.01 [0.97-1.05],0.745975237750937,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD46,Membrane cofactor protein,Wald ratio,1,0.96 [0.76-1.22],0.746541048467714,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.99 [0.91-1.07],0.749837124929849,cis
Chapter IX Diseases of the circulatory system,I9_VTE,KLK11,Kallikrein-11,Inverse variance weighted,6,0.99 [0.95-1.04],0.753388224450779,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PSAP,Prosaposin,Inverse variance weighted,5,1.02 [0.9-1.16],0.759777864204025,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNC,Tenascin,Inverse variance weighted,12,0.99 [0.92-1.07],0.76198262430517,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.01 [0.93-1.1],0.764704307651436,cis
Chapter IX Diseases of the circulatory system,I9_VTE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.02 [0.89-1.18],0.765275587615396,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD248,Endosialin,Inverse variance weighted,2,1.06 [0.7-1.61],0.776579959296353,cis
Chapter IX Diseases of the circulatory system,I9_VTE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.94 [0.59-1.48],0.778226619501597,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.01 [0.95-1.07],0.780195803973653,cis
Chapter IX Diseases of the circulatory system,I9_VTE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.95 [0.65-1.38],0.783582256026664,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.03 [0.86-1.23],0.784845454765484,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.95 [0.67-1.35],0.785150331550208,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LAYN,Layilin,Inverse variance weighted,20,1.01 [0.95-1.07],0.785609527395086,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.01 [0.95-1.07],0.800351424141275,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.99 [0.94-1.05],0.809651759263055,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SCG2,Secretogranin-2,Wald ratio,1,1.05 [0.68-1.64],0.813044843302953,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,0.98 [0.85-1.14],0.820287485625879,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.01 [0.91-1.12],0.82240972714466,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.01 [0.95-1.06],0.835615155570095,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LMNB2,Lamin-B2,Wald ratio,1,1.06 [0.63-1.77],0.835940574189704,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.01 [0.94-1.08],0.845479238779045,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.99 [0.88-1.11],0.848684625985449,cis
Chapter IX Diseases of the circulatory system,I9_VTE,MATN2,Matrilin-2,Inverse variance weighted,18,1.01 [0.94-1.08],0.856158069687442,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.99 [0.93-1.06],0.859251516065621,cis
Chapter IX Diseases of the circulatory system,I9_VTE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1 [0.96-1.05],0.860749281950465,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.97 [0.65-1.43],0.860875994801334,cis
Chapter IX Diseases of the circulatory system,I9_VTE,EPO,Erythropoietin,Inverse variance weighted,5,1.02 [0.8-1.31],0.861744089639346,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NECTIN4,Nectin-4,Inverse variance weighted,7,0.99 [0.92-1.07],0.869405126987111,cis
Chapter IX Diseases of the circulatory system,I9_VTE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.01 [0.92-1.1],0.878300613844955,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.01 [0.89-1.15],0.88158515575575,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.97 [0.59-1.57],0.885716797143211,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ACAN,Aggrecan core protein,Inverse variance weighted,3,1.01 [0.83-1.23],0.886270276561658,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.98 [0.71-1.36],0.893945762783228,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CST3,Cystatin-C,Inverse variance weighted,10,1 [0.93-1.07],0.894635971832785,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.99 [0.91-1.09],0.894830954185654,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,11,1 [0.92-1.07],0.898132780948011,cis
Chapter IX Diseases of the circulatory system,I9_VTE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.01 [0.86-1.19],0.900047847790163,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1 [0.95-1.05],0.907359226449689,cis
Chapter IX Diseases of the circulatory system,I9_VTE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.02 [0.73-1.41],0.911757215125171,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD302,CD302 antigen,Inverse variance weighted,9,1 [0.93-1.07],0.916383386150311,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.99 [0.78-1.25],0.916639107628943,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.99 [0.83-1.18],0.920830090486087,cis
Chapter IX Diseases of the circulatory system,I9_VTE,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.02 [0.71-1.45],0.922056506613941,cis
Chapter IX Diseases of the circulatory system,I9_VTE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1 [0.97-1.04],0.929957624546283,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PTN,Pleiotrophin,Inverse variance weighted,4,0.99 [0.73-1.34],0.940210501856691,cis
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.98 [0.57-1.69],0.946017850594542,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,1 [0.97-1.03],0.956744748681577,cis
Chapter IX Diseases of the circulatory system,I9_VTE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1 [0.91-1.09],0.964916151577238,cis
Chapter IX Diseases of the circulatory system,I9_VTE,MSLN,Mesothelin,Inverse variance weighted,25,1 [0.96-1.04],0.986017360743268,cis
Chapter IX Diseases of the circulatory system,I9_VTE,PALM,Paralemmin-1,Inverse variance weighted,6,1 [0.9-1.11],0.990450197095886,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1 [0.78-1.28],0.993525723062857,cis
Chapter IX Diseases of the circulatory system,I9_VTE,CD48,CD48 antigen,Inverse variance weighted,18,1 [0.96-1.04],0.999763916546263,cis
Chapter IX Diseases of the circulatory system,I9_VTE,ABO,Histo-blood group ABO system transferase,Inverse variance weighted,36,1.22 [1.15-1.28],7.41288263189238e-13,trans
Chapter IX Diseases of the circulatory system,I9_VTE,THBD,Thrombomodulin,Inverse variance weighted,11,1.44 [1.26-1.65],1.38652207748904e-07,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.54 [0.42-0.7],3.17681752631608e-06,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.48 [1.25-1.74],3.23540619856434e-06,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PCDH17,Protocadherin-17,Inverse variance weighted,44,1.17 [1.09-1.26],3.11054699164628e-05,trans
Chapter IX Diseases of the circulatory system,I9_VTE,VWF,von Willebrand factor,Inverse variance weighted,6,1.73 [1.32-2.27],6.99464562482606e-05,trans
Chapter IX Diseases of the circulatory system,I9_VTE,OGN,Mimecan,Inverse variance weighted,37,0.91 [0.88-0.96],7.25100834649063e-05,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.21 [1.1-1.33],0.000110083257201722,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.47 [1.19-1.81],0.000307139994031815,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.6 [1.24-2.08],0.00036287625720453,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.28 [1.09-1.5],0.00200923579639205,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.53 [1.16-2.02],0.00283178260641377,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.35 [1.11-1.65],0.00333676236891652,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NRP2,Neuropilin-2,Inverse variance weighted,14,1.35 [1.1-1.65],0.00364102804276641,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.92 [1.23-3],0.00396082241582698,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.58 [1.12-2.24],0.00883713036807121,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.19 [1.04-1.36],0.00968369421130108,trans
Chapter IX Diseases of the circulatory system,I9_VTE,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,24,1.18 [1.04-1.33],0.00997331934574497,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.66 [0.48-0.92],0.0131477254367172,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,1.14 [1.03-1.26],0.0135427541130472,trans
Chapter IX Diseases of the circulatory system,I9_VTE,BSG,Basigin,Inverse variance weighted,6,1.31 [1.05-1.62],0.0145593263348033,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.19 [1.03-1.38],0.0165900625106372,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.09 [1.02-1.17],0.017069022501517,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.81 [0.68-0.96],0.0171888442966197,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,11,0.9 [0.82-0.98],0.021133957505455,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.72 [0.54-0.95],0.0214404392388399,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.39 [1.05-1.85],0.0216003541097162,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.73 [0.55-0.97],0.0288066917751513,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNC,Tenascin,Inverse variance weighted,57,1.05 [1-1.09],0.0299515358028788,trans
Chapter IX Diseases of the circulatory system,I9_VTE,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.13 [1.01-1.27],0.035364853005924,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.1 [1.01-1.2],0.0363646863697412,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.95 [0.91-1],0.0414857248989109,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.23 [1.01-1.49],0.043236686742397,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.22 [1.01-1.47],0.0435436331662728,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.15 [1-1.32],0.0512212817050574,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PALM2,Paralemmin-2,Inverse variance weighted,9,1.11 [1-1.23],0.051789486438525,trans
Chapter IX Diseases of the circulatory system,I9_VTE,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.19 [1-1.43],0.0551957324873482,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.84 [0.71-1.01],0.0571173904709771,trans
Chapter IX Diseases of the circulatory system,I9_VTE,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.66 [0.98-2.81],0.0581535342472394,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,1.05 [1-1.11],0.0601160991454518,trans
Chapter IX Diseases of the circulatory system,I9_VTE,VCAN,Versican core protein,Inverse variance weighted,30,1.07 [1-1.14],0.0605531456642425,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,1.15 [0.99-1.34],0.0696363243379065,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.84 [0.7-1.02],0.0728233524760112,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CTSL,Cathepsin L1,Inverse variance weighted,29,1.08 [0.99-1.18],0.0789478654714691,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SPON2,Spondin-2,Inverse variance weighted,3,1.28 [0.97-1.7],0.0845635079512815,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.26 [0.96-1.63],0.0905765734510477,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MATN2,Matrilin-2,Inverse variance weighted,28,1.05 [0.99-1.1],0.0909927501485675,trans
Chapter IX Diseases of the circulatory system,I9_VTE,DRAXIN,Draxin,Inverse variance weighted,25,1.12 [0.98-1.27],0.0965659940060614,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.23 [0.96-1.58],0.0987940152090592,trans
Chapter IX Diseases of the circulatory system,I9_VTE,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.07 [0.99-1.16],0.102949385703341,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.09 [0.98-1.22],0.103738056860321,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.81 [0.62-1.05],0.104657631444518,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.2 [0.96-1.49],0.11124945367236,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.83 [0.66-1.05],0.112795130878046,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.05 [0.99-1.13],0.118749658082131,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.92 [0.84-1.02],0.120224595208695,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.95 [0.89-1.01],0.124579679549083,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.1 [0.97-1.25],0.127595524689615,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.06 [0.98-1.14],0.129283213176934,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IL6,Interleukin-6,Inverse variance weighted,6,1.07 [0.98-1.17],0.1296399360779,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.11 [0.97-1.26],0.131963298220917,trans
Chapter IX Diseases of the circulatory system,I9_VTE,AREG,Amphiregulin,Inverse variance weighted,5,1.16 [0.96-1.39],0.134014122240762,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.95 [0.9-1.01],0.137106483574646,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.06 [0.98-1.15],0.137407533506031,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.11 [0.97-1.27],0.140265507530834,trans
Chapter IX Diseases of the circulatory system,I9_VTE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.06 [0.98-1.16],0.143460950924688,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MMP3,Stromelysin-1,Inverse variance weighted,4,0.67 [0.39-1.15],0.143753603896464,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.21 [0.93-1.58],0.151235168244197,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NECTIN4,Nectin-4,Inverse variance weighted,4,0.39 [0.11-1.41],0.152975774180163,trans
Chapter IX Diseases of the circulatory system,I9_VTE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.2 [0.93-1.54],0.158797399020195,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.14 [0.95-1.37],0.159074374160573,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IL15,Interleukin-15,Inverse variance weighted,35,0.95 [0.89-1.02],0.159091951609681,trans
Chapter IX Diseases of the circulatory system,I9_VTE,KLK4,Kallikrein-4,Inverse variance weighted,5,0.83 [0.64-1.08],0.160217107316931,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.93 [0.85-1.03],0.162143865302954,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.17 [0.94-1.47],0.164849727619602,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.21 [0.92-1.58],0.165363428784932,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.31 [0.89-1.93],0.165450485490561,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.83 [0.64-1.09],0.176350264813744,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.18 [0.92-1.52],0.181737965254776,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.05 [0.98-1.13],0.188254936103774,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.95 [0.87-1.03],0.18828174491092,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,1.07 [0.97-1.19],0.189542674570034,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.1 [0.95-1.28],0.19112164598512,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.43 [0.84-2.44],0.191206282294913,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,1.07 [0.97-1.17],0.196582800578566,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LGALS9,Galectin-9,Inverse variance weighted,36,0.96 [0.9-1.02],0.19774511587945,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RSPO3,R-spondin-3,Inverse variance weighted,5,0.89 [0.75-1.07],0.208189305360889,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.27 [0.87-1.85],0.212239322327933,trans
Chapter IX Diseases of the circulatory system,I9_VTE,BGLAP,Osteocalcin,Inverse variance weighted,8,1.14 [0.92-1.41],0.216402289072314,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.92 [0.8-1.05],0.223771197143536,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.23 [0.88-1.74],0.226773034008426,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.84 [0.63-1.12],0.229641411237371,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.85 [0.64-1.11],0.235801584758233,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.15 [0.91-1.44],0.241617427231609,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.88 [0.72-1.09],0.241815106535147,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.17 [0.89-1.55],0.255389227036935,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.96 [0.89-1.03],0.257526724009665,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CST3,Cystatin-C,Inverse variance weighted,3,1.18 [0.89-1.56],0.258024630829253,trans
Chapter IX Diseases of the circulatory system,I9_VTE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.96 [0.89-1.03],0.260038309001487,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.21 [0.87-1.69],0.264902123825917,trans
Chapter IX Diseases of the circulatory system,I9_VTE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.07 [0.95-1.2],0.266879361538045,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NECTIN2,Nectin-2,Inverse variance weighted,3,0.28 [0.03-2.66],0.268658682611075,trans
Chapter IX Diseases of the circulatory system,I9_VTE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.24 [0.84-1.82],0.271954373113579,trans
Chapter IX Diseases of the circulatory system,I9_VTE,DSC2,Desmocollin-2,Inverse variance weighted,16,1.05 [0.97-1.13],0.272911394459778,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ELN,Elastin,Inverse variance weighted,10,1.08 [0.94-1.24],0.277971327603651,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.05 [0.96-1.16],0.279001443561779,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.11 [0.92-1.35],0.279961627875454,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.86 [0.64-1.14],0.284644384034005,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.78 [0.49-1.24],0.294666666893494,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD83,CD83 antigen,Inverse variance weighted,14,0.94 [0.85-1.05],0.296146562497531,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.98 [0.93-1.02],0.30252109803972,trans
Chapter IX Diseases of the circulatory system,I9_VTE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.83 [0.58-1.18],0.305629863303282,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.96 [0.88-1.04],0.314371080521579,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,0.91 [0.76-1.09],0.316261947873497,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.1 [0.91-1.33],0.316343838386443,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.22 [0.82-1.81],0.32228643283603,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.94 [0.83-1.06],0.323930381381053,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.98 [0.94-1.02],0.324184679127536,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.92 [0.78-1.09],0.324745550356065,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.35 [0.74-2.46],0.325083611274005,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.02 [0.98-1.06],0.331573944026625,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.08 [0.92-1.26],0.33868875572656,trans
Chapter IX Diseases of the circulatory system,I9_VTE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.87 [0.65-1.16],0.342324770913203,trans
Chapter IX Diseases of the circulatory system,I9_VTE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.91 [0.74-1.11],0.345771973702611,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.26 [0.78-2.04],0.348449087232932,trans
Chapter IX Diseases of the circulatory system,I9_VTE,VWC2,Brorin,Inverse variance weighted,12,0.93 [0.8-1.08],0.35113141536256,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.28 [0.76-2.13],0.351862298962343,trans
Chapter IX Diseases of the circulatory system,I9_VTE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.06 [0.94-1.19],0.352014832187199,trans
Chapter IX Diseases of the circulatory system,I9_VTE,AMBP,Protein AMBP,Inverse variance weighted,5,1.07 [0.93-1.23],0.355220409641307,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.08 [0.92-1.26],0.367505868253587,trans
Chapter IX Diseases of the circulatory system,I9_VTE,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.07 [0.92-1.25],0.368344670268493,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CDH3,Cadherin-3,Inverse variance weighted,10,1.08 [0.91-1.28],0.368403779149247,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.09 [0.91-1.3],0.371275296979455,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.8 [0.49-1.31],0.372203948804839,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.19 [0.81-1.74],0.37336885745402,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.74 [0.38-1.44],0.377943328548303,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD248,Endosialin,Inverse variance weighted,17,1.05 [0.94-1.18],0.379108662955459,trans
Chapter IX Diseases of the circulatory system,I9_VTE,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.15 [0.84-1.57],0.382859630011727,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.1 [0.89-1.37],0.383759301305538,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.11 [0.88-1.4],0.385435427042602,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.12 [0.87-1.45],0.385941126240947,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.03 [0.97-1.09],0.38856452893076,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SEPTIN8,Septin-8,Inverse variance weighted,4,1.09 [0.9-1.32],0.390016053119285,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SDC1,Syndecan-1,Inverse variance weighted,12,1.08 [0.9-1.3],0.393839998915613,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PSAP,Prosaposin,Inverse variance weighted,13,1.04 [0.95-1.12],0.405416351021702,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SPON1,Spondin-1,Inverse variance weighted,4,0.79 [0.45-1.39],0.406228430706826,trans
Chapter IX Diseases of the circulatory system,I9_VTE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.18 [0.8-1.74],0.408284639851812,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.09 [0.89-1.33],0.414153468113318,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.98 [0.93-1.03],0.414154484390008,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.07 [0.91-1.25],0.416754854415442,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.18 [0.79-1.76],0.41716150766122,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.07 [0.9-1.28],0.423126169176024,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LMNB2,Lamin-B2,Inverse variance weighted,8,0.94 [0.8-1.1],0.425058235767377,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.05 [0.93-1.17],0.425983716596565,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IL17C,Interleukin-17C,Inverse variance weighted,5,0.92 [0.75-1.13],0.430341448839206,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD302,CD302 antigen,Inverse variance weighted,11,1.04 [0.94-1.15],0.436649766169211,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.03 [0.96-1.1],0.445494305721893,trans
Chapter IX Diseases of the circulatory system,I9_VTE,F10,Coagulation factor X,Inverse variance weighted,11,1.1 [0.87-1.39],0.446444010663673,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MATN3,Matrilin-3,Inverse variance weighted,4,0.74 [0.34-1.61],0.451294647590288,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.04 [0.94-1.14],0.464594443572093,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.93 [0.77-1.13],0.464943615070989,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CSTB,Cystatin-B,Inverse variance weighted,23,0.98 [0.94-1.03],0.466028710885938,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.95 [0.81-1.1],0.469029542007177,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,0.89 [0.66-1.21],0.470885610344233,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.06 [0.9-1.24],0.473475185473798,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,0.9 [0.66-1.22],0.489396950003106,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.84 [0.52-1.37],0.492631706066531,trans
Chapter IX Diseases of the circulatory system,I9_VTE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.04 [0.93-1.16],0.500991252168873,trans
Chapter IX Diseases of the circulatory system,I9_VTE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.94 [0.78-1.13],0.501335675514586,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.95 [0.82-1.1],0.503829273933312,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FBLN2,Fibulin-2,Inverse variance weighted,6,1.11 [0.81-1.51],0.507575970936497,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD48,CD48 antigen,Inverse variance weighted,14,1.05 [0.91-1.2],0.511706386536701,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,1.05 [0.91-1.2],0.515047194775262,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.07 [0.88-1.3],0.515698654712553,trans
Chapter IX Diseases of the circulatory system,I9_VTE,COLEC12,Collectin-12,Inverse variance weighted,3,1.15 [0.76-1.74],0.519819283130562,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EPO,Erythropoietin,Inverse variance weighted,11,1.05 [0.91-1.2],0.52081136610588,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.86 [0.55-1.36],0.521937308685156,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.1 [0.82-1.49],0.531587319765192,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.76 [0.33-1.78],0.531725310289905,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.06 [0.89-1.26],0.536548249598589,trans
Chapter IX Diseases of the circulatory system,I9_VTE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.88 [0.58-1.32],0.538979364319787,trans
Chapter IX Diseases of the circulatory system,I9_VTE,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.06 [0.88-1.27],0.541799427740915,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.07 [0.85-1.35],0.542903219703389,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.07 [0.87-1.31],0.543901645132149,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.95 [0.82-1.11],0.544527491088892,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD99,CD99 antigen,Inverse variance weighted,4,0.93 [0.73-1.18],0.546084723568152,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MSLN,Mesothelin,Inverse variance weighted,11,1.04 [0.92-1.17],0.547657531301005,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.87 [0.55-1.38],0.55202989377669,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.08 [0.84-1.38],0.56427047071277,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.1 [0.8-1.5],0.567788768231385,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.09 [0.8-1.49],0.568389514828999,trans
Chapter IX Diseases of the circulatory system,I9_VTE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.98 [0.91-1.05],0.568407356726253,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.08 [0.83-1.39],0.576599316830072,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SCG2,Secretogranin-2,Inverse variance weighted,2,0.9 [0.62-1.3],0.57776747182417,trans
Chapter IX Diseases of the circulatory system,I9_VTE,DPT,Dermatopontin,Inverse variance weighted,4,0.9 [0.62-1.31],0.582852578003247,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NID1,Nidogen-1,Inverse variance weighted,6,0.96 [0.83-1.11],0.585426005247345,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.04 [0.91-1.19],0.587688737125647,trans
Chapter IX Diseases of the circulatory system,I9_VTE,GAST,Gastrin,Inverse variance weighted,9,0.97 [0.86-1.09],0.588536660967927,trans
Chapter IX Diseases of the circulatory system,I9_VTE,WNT9A,Protein Wnt-9a,Wald ratio,1,0.85 [0.47-1.53],0.592342692756482,trans
Chapter IX Diseases of the circulatory system,I9_VTE,AGRN,Agrin,Inverse variance weighted,14,1.05 [0.87-1.28],0.603503770181207,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.01 [0.96-1.07],0.606294873194542,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.05 [0.86-1.29],0.608596219455919,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.07 [0.82-1.39],0.611616492497016,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD27,CD27 antigen,Inverse variance weighted,9,1.04 [0.89-1.21],0.621870551523962,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ACAN,Aggrecan core protein,Inverse variance weighted,30,0.98 [0.9-1.06],0.6234700312617,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.97 [0.85-1.1],0.62635012167309,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.09 [0.77-1.54],0.627318610621853,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.93 [0.69-1.25],0.63297580780552,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.02 [0.95-1.09],0.634238278873529,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LAYN,Layilin,Inverse variance weighted,3,1.07 [0.8-1.43],0.635880681896932,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.04 [0.87-1.24],0.649874211201822,trans
Chapter IX Diseases of the circulatory system,I9_VTE,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.06 [0.83-1.35],0.651807844400866,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.97 [0.84-1.12],0.654863847164641,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.99 [0.94-1.04],0.655037349822597,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.91 [0.59-1.4],0.659867628666518,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,1.06 [0.81-1.38],0.669110332309135,trans
Chapter IX Diseases of the circulatory system,I9_VTE,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.03 [0.9-1.18],0.671485341054464,trans
Chapter IX Diseases of the circulatory system,I9_VTE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.03 [0.9-1.18],0.679681095038044,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.94 [0.71-1.25],0.684515627515673,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.86 [0.39-1.86],0.693190249562078,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.99 [0.95-1.03],0.727841954764316,trans
Chapter IX Diseases of the circulatory system,I9_VTE,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.97 [0.84-1.13],0.730563719502092,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RSPO1,R-spondin-1,Inverse variance weighted,8,1.03 [0.88-1.2],0.731018507817992,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.97 [0.8-1.17],0.735277810122872,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.01 [0.96-1.05],0.744274862852497,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.06 [0.73-1.54],0.744920231354857,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.98 [0.86-1.11],0.745892219428532,trans
Chapter IX Diseases of the circulatory system,I9_VTE,OCLN,Occludin,Inverse variance weighted,2,0.94 [0.64-1.38],0.750730563134718,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.04 [0.8-1.36],0.752184838565916,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.06 [0.73-1.55],0.753492109707433,trans
Chapter IX Diseases of the circulatory system,I9_VTE,F7,Coagulation factor VII,Inverse variance weighted,10,1.05 [0.75-1.48],0.762915455205857,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.03 [0.83-1.28],0.765241769229623,trans
Chapter IX Diseases of the circulatory system,I9_VTE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.01 [0.94-1.08],0.769494382016838,trans
Chapter IX Diseases of the circulatory system,I9_VTE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.02 [0.91-1.14],0.779814133392295,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.04 [0.77-1.42],0.784488806887052,trans
Chapter IX Diseases of the circulatory system,I9_VTE,XG,Glycoprotein Xg,Inverse variance weighted,2,0.95 [0.67-1.35],0.788342473220563,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.03 [0.84-1.26],0.788449257592862,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.02 [0.87-1.19],0.798845163801036,trans
Chapter IX Diseases of the circulatory system,I9_VTE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.97 [0.79-1.2],0.799375318860252,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MB,Myoglobin,Inverse variance weighted,9,1.02 [0.85-1.24],0.804491922388169,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.02 [0.9-1.15],0.806163626674271,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,0.99 [0.92-1.07],0.817259124987033,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PGF,Placenta growth factor,Inverse variance weighted,5,1.02 [0.85-1.23],0.821110864412777,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.01 [0.91-1.12],0.82240972714466,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.91 [0.37-2.21],0.830232700208121,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.97 [0.77-1.24],0.834736399753861,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.95 [0.55-1.63],0.839492982659923,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.01 [0.94-1.08],0.843238022004774,trans
Chapter IX Diseases of the circulatory system,I9_VTE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.01 [0.94-1.08],0.848692265770662,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.02 [0.86-1.2],0.849572668297561,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PALM,Paralemmin-1,Inverse variance weighted,4,0.97 [0.73-1.3],0.854390572588185,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,1.18 [0.18-7.54],0.861300936231602,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CX3CL1,Fractalkine,Inverse variance weighted,12,1.02 [0.84-1.24],0.868467374116716,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PTPRF,Receptor-type tyrosine-protein phosphatase F,Inverse variance weighted,17,1.01 [0.84-1.23],0.881681447549466,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.97 [0.69-1.38],0.882360850383806,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CCN3,CCN family member 3,Inverse variance weighted,17,1 [0.94-1.07],0.883236954076504,trans
Chapter IX Diseases of the circulatory system,I9_VTE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.02 [0.81-1.27],0.884045539553201,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1 [0.94-1.06],0.900904953553606,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.99 [0.83-1.17],0.904956382203423,trans
Chapter IX Diseases of the circulatory system,I9_VTE,SPP1,Osteopontin,Inverse variance weighted,13,1.01 [0.86-1.18],0.905446302085573,trans
Chapter IX Diseases of the circulatory system,I9_VTE,KLK11,Kallikrein-11,Inverse variance weighted,13,1.01 [0.91-1.12],0.916364272774713,trans
Chapter IX Diseases of the circulatory system,I9_VTE,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.99 [0.75-1.3],0.917136053905065,trans
Chapter IX Diseases of the circulatory system,I9_VTE,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.99 [0.8-1.22],0.918351448635161,trans
Chapter IX Diseases of the circulatory system,I9_VTE,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.97 [0.52-1.79],0.921836418765905,trans
Chapter IX Diseases of the circulatory system,I9_VTE,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.03 [0.58-1.81],0.930286051105786,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.99 [0.78-1.26],0.938952884881629,trans
Chapter IX Diseases of the circulatory system,I9_VTE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.99 [0.72-1.36],0.939024392935702,trans
Chapter IX Diseases of the circulatory system,I9_VTE,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1.01 [0.82-1.23],0.957941332944403,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.99 [0.75-1.32],0.959623585964232,trans
Chapter IX Diseases of the circulatory system,I9_VTE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1 [0.88-1.13],0.959902187046839,trans
Chapter IX Diseases of the circulatory system,I9_VTE,PTN,Pleiotrophin,Inverse variance weighted,3,1 [0.79-1.25],0.965327270574138,trans
Chapter IX Diseases of the circulatory system,I9_VTE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.99 [0.73-1.36],0.970409364706077,trans
Chapter IX Diseases of the circulatory system,I9_VTE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1 [0.88-1.14],0.971529092542318,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1 [0.95-1.06],0.976201777884629,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CHGA,Chromogranin-A,Inverse variance weighted,5,1 [0.85-1.17],0.982348820356986,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TFF2,Trefoil factor 2,Inverse variance weighted,16,1 [0.92-1.09],0.985596288006044,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CD276,CD276 antigen,Inverse variance weighted,24,1 [0.93-1.08],0.987513984392554,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1 [0.91-1.09],0.991871886027627,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CKB,Creatine kinase B-type,Inverse variance weighted,11,1 [0.76-1.31],0.992095004697152,trans
Chapter IX Diseases of the circulatory system,I9_VTE,TFF3,Trefoil factor 3,Inverse variance weighted,10,1 [0.88-1.14],0.995064224782855,trans
Chapter IX Diseases of the circulatory system,I9_VTE,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1 [0.93-1.08],0.997649178153569,trans
